Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Several years ago, when Soloman first started dumpage, he kept the total number of outstanding shares about the same by turning in a matching number of his personal shares to make up for the dumpage.
I see no reason that we shouldn't request he continue this practice right now.
Zecotek Display Systems and Institute of Chemical Physics Develop Metal Alloys for 3D Printing
July 24, 2014
Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing
Singapore, July 24, 2014 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. has signed an agreement with the Institute of Chemical Physics of the National Academy of Sciences in Yerevan, Armenia, to extend the list of high-performance powder metal alloys for use in its compact, high-speed 3D printer. The Institute will work with Zecotek and LT-Pyrkal to fine tune the advanced technology necessary for the fabrication of metal powders from metal hydride compounds. The focus of the contract is to maintain a leadership position in the production of high-performance powder materials that can be used in 3D additive manufacture of metal and alloys based components for very wide applications and industries at large.
“By partnering with industry leaders such as the Institute of Chemical Physics and LT-Pyrkal, Zecotek Display Systems is establishing a solid foundation to become leader in 3D printing as well as powder materials for prototyping and distributed manufacturing,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “We have formed a trilateral partnership which immediately adds value to our 3D printing program. The Institute of Chemical Physics is a leading developer of new materials, a critical factor as traditional industrial production transitions to 3D rapid manufacturing. Not only are we establishing Zecotek as a leader in industrial 3D printing, with this announcement we are positioning our division to become a leader in the supply of new materials to support the industry. We look forward to working with this impressive group of scientific professionals to advance our 3D printing technologies.”
“The collaboration between Zecotek Display Systems, LT-Pyrkal, and the Institute of Chemical Physics will focus on 3D printing systems and high-performance materials applicable in additive manufacturing technologies” said Dr. Levon A. Tavadyan, Director of the Institute of Chemical Physics. “We are excited by the opportunity to produce these types of materials for fast 3D printing, and establish with Zecotek, the partnership as a leading supplier of powder metals, alloys and hydride compounds for 3D rapid manufacturing. The new materials will be used in the laser sintering based 3D printing developed by Zecotek and LT-Pyrkal for prototyping and mass production.”
The Institute of Chemical Physics has established itself as a preeminent organization for the advancement of chemical physics. Based in Yerevan, Armenia it was founded in the early 1960s and took its present structure in 1975. The Institute has completed extensive research in the areas of processing hydrocarbons and natural mineral raw materials into the valuable products and combustion processes in solid systems (self-propagating high-temperature synthesis.
Zecotek and LT-Pyrkal have identified a unique method of printing with high-performance metal alloys with its proprietary compact, high-speed 3D printing technologies. The development of new of powder metals, alloys and hydride compounds in rapid prototyping and rapid manufacturing, will be a significant leap forward for those companies looking for higher productivity, economical customization, improved quality and greater efficiency through rapid prototyping and rapid manufacturing.
-30-
About the Institute of Chemical Physics
The Institute of Chemical Physics is based in Yerevan, Armenia and is part of Russia`s International Science and Technology Centre, an intergovernmental organization connecting scientists from Russia, Georgia and other countries of the Commonwealth of Independent States (CIS) with their peers and research organizations in the EU, Japan, Republic of Korea, Norway and the United States. The organization specializes in the development of the theory of chemical conversion, kinetics and a mechanism of complex chemical reactions proceeding with a participation of free radicals and atoms, including chain reaction as well as combustion and explosion in the gas and condensed phases. Its main fields of activity include: complex and elementary chemical reactions with a participation of free radicals; chemistry of free radicals; chain reactions; combustion and explosion in the gas and condensed phases; synthesis of inorganic materials under condition of combustion; development of technologies of refractory material production by means of SHS (self-propagating high temperature synthesis) method; catalytic processes; heterophase chemical processes. For more information visit: http://www.istc.ru/istc/db/inst.nsf/wsu/i0001716?OpenDocument&lang=Eng.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Michael Minder
Zecotek Photonics Inc.
Unit 1120 – 21331 Gordon Way
Richmond, BC V6W 1J9
T: (604) 783-8291
ir@zecotek.com
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors – mining, oil & gas, technology & life sciences, diversified industries and clean technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Zecotek Display Systems and Institute of Chemical Physics Develop Metal Alloys for 3D Printing
July 24, 2014
Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing
Singapore, July 24, 2014 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. has signed an agreement with the Institute of Chemical Physics of the National Academy of Sciences in Yerevan, Armenia, to extend the list of high-performance powder metal alloys for use in its compact, high-speed 3D printer. The Institute will work with Zecotek and LT-Pyrkal to fine tune the advanced technology necessary for the fabrication of metal powders from metal hydride compounds. The focus of the contract is to maintain a leadership position in the production of high-performance powder materials that can be used in 3D additive manufacture of metal and alloys based components for very wide applications and industries at large.
“By partnering with industry leaders such as the Institute of Chemical Physics and LT-Pyrkal, Zecotek Display Systems is establishing a solid foundation to become leader in 3D printing as well as powder materials for prototyping and distributed manufacturing,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “We have formed a trilateral partnership which immediately adds value to our 3D printing program. The Institute of Chemical Physics is a leading developer of new materials, a critical factor as traditional industrial production transitions to 3D rapid manufacturing. Not only are we establishing Zecotek as a leader in industrial 3D printing, with this announcement we are positioning our division to become a leader in the supply of new materials to support the industry. We look forward to working with this impressive group of scientific professionals to advance our 3D printing technologies.”
“The collaboration between Zecotek Display Systems, LT-Pyrkal, and the Institute of Chemical Physics will focus on 3D printing systems and high-performance materials applicable in additive manufacturing technologies” said Dr. Levon A. Tavadyan, Director of the Institute of Chemical Physics. “We are excited by the opportunity to produce these types of materials for fast 3D printing, and establish with Zecotek, the partnership as a leading supplier of powder metals, alloys and hydride compounds for 3D rapid manufacturing. The new materials will be used in the laser sintering based 3D printing developed by Zecotek and LT-Pyrkal for prototyping and mass production.”
The Institute of Chemical Physics has established itself as a preeminent organization for the advancement of chemical physics. Based in Yerevan, Armenia it was founded in the early 1960s and took its present structure in 1975. The Institute has completed extensive research in the areas of processing hydrocarbons and natural mineral raw materials into the valuable products and combustion processes in solid systems (self-propagating high-temperature synthesis.
Zecotek and LT-Pyrkal have identified a unique method of printing with high-performance metal alloys with its proprietary compact, high-speed 3D printing technologies. The development of new of powder metals, alloys and hydride compounds in rapid prototyping and rapid manufacturing, will be a significant leap forward for those companies looking for higher productivity, economical customization, improved quality and greater efficiency through rapid prototyping and rapid manufacturing.
-30-
About the Institute of Chemical Physics
The Institute of Chemical Physics is based in Yerevan, Armenia and is part of Russia`s International Science and Technology Centre, an intergovernmental organization connecting scientists from Russia, Georgia and other countries of the Commonwealth of Independent States (CIS) with their peers and research organizations in the EU, Japan, Republic of Korea, Norway and the United States. The organization specializes in the development of the theory of chemical conversion, kinetics and a mechanism of complex chemical reactions proceeding with a participation of free radicals and atoms, including chain reaction as well as combustion and explosion in the gas and condensed phases. Its main fields of activity include: complex and elementary chemical reactions with a participation of free radicals; chemistry of free radicals; chain reactions; combustion and explosion in the gas and condensed phases; synthesis of inorganic materials under condition of combustion; development of technologies of refractory material production by means of SHS (self-propagating high temperature synthesis) method; catalytic processes; heterophase chemical processes. For more information visit: http://www.istc.ru/istc/db/inst.nsf/wsu/i0001716?OpenDocument&lang=Eng.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Michael Minder
Zecotek Photonics Inc.
Unit 1120 – 21331 Gordon Way
Richmond, BC V6W 1J9
T: (604) 783-8291
ir@zecotek.com
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors – mining, oil & gas, technology & life sciences, diversified industries and clean technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Zecotek & LT-PYRKAL Announce High-Performance 3D Printer
July 21, 2014
Zecotek Display Systems and LT-PYRKAL Testing Proprietary High-Performance Material 3D Printer
Singapore, July 21, 2014 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. has contracted LT-PYRKAL of Yerevan, Armenia, to assemble and test its first compact, high-speed 3D printer which will use high-performance metal alloys and offer technical and commercial advantages over other 3D printing technology. Zecotek and LT-Pyrkal previously announced a partnership in February 2014. Since that time a number of key technical challenges have been solved and LT-Pyrkal will now proceed with the assembly of the new 3D printer, which will be used for both prototyping and distributed manufacturing with specific applications in electronics, aerospace, automotive, mechanical and healthcare industries.
“With our partner LT-PYRKAL, we are assembling and testing our first 3D printer which will have the ability to use an extended and varied list of alloys to “print” metal components for targeted industries,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our technical team of scientists have identified a unique approach to handle high-performance metal alloys with our compact high-speed 3D print technologies. The advantage of our design is the compactness, speed and quick transition from prototyping to 3D manufacturing at all levels of production. Add the ability to handle high-performance metal alloys and the size of the market grows considerably. We are excited about the prospect of being a key leader in an industry that will revolutionize manufacturing.”
LT-PYRKAL is a long time contract partner of Zecotek which developed a number of key electro-mechanical elements for Zecotek`s patented 3D display technology. The company is known for its experience in automation systems, component design and product development across many industries. It has working relations with both small and large organizations and has completed large projects for local government agencies.
“We look forward to continuing to build on our growing relationship with Zecotek by completing the assembly and testing of their first compact high-speed 3D printer and assist them to move to full production and sales,” said Mr. Gagik Buniatyan, General Director of LT-PYRKAL.
3D printing is the process of making three dimensional solid objects from a digital model by laying down successive layers of material in different shapes. Zecotek and LT-PYRKAL have identified a unique method of printing with high-performance metal alloys with its proprietary compact, high-speed 3D printing technologies. This will provide companies to evaluate a broader range of product models in less time to improve design throughout the product development process. Rapid prototyping enables faster more efficient production, while rapid manufacturing enables higher productivity, economical customization, improved quality and greater efficiency.
Total annual sales and service of 3D printers has reached $2 billion. Leading industry analysts predict continued significant growth with annual sales of 3D printing reaching $4 billion by 2015, and over $10 billion by 2021. The rapid growth in the 3D printing market is due to the improving performance of additive equipment and the expanding range of materials being used. Although 3D printing has now become cheaper and more customizable than regular manufacturing methods, Zecotek and LT-PYRKAL have identified a number of opportunities to improve 3D printing technology. Patents will be filed as required.
-30-
About LT-PYRKAL
LT-PYRKAL is a Greek-Armenian research, development and production company, specializing in crystal growth, laser accessories and components, lasers and systems. LT-PYRKAL was established in 1999 and today employs over 250 highly qualified specialists and occupies over 30,000 square meters of industrial facilities for synthetic crystal growth, opto-mechanics and laser electronics manufacturing, and laser and EO Systems development. For more information please visit: http://www.lt-pyrkal.com/en/.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Michael Minder
Zecotek Photonics Inc.
Unit 1120 – 21331 Gordon Way
Richmond, BC V6W 1J9
T: (604) 783-8291
ir@zecotek.com
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors – mining, oil & gas, technology & life sciences, diversified industries and clean technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Zecotek & LT-PYRKAL Announce High-Performance 3D Printer
July 21, 2014
Zecotek Display Systems and LT-PYRKAL Testing Proprietary High-Performance Material 3D Printer
Singapore, July 21, 2014 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. has contracted LT-PYRKAL of Yerevan, Armenia, to assemble and test its first compact, high-speed 3D printer which will use high-performance metal alloys and offer technical and commercial advantages over other 3D printing technology. Zecotek and LT-Pyrkal previously announced a partnership in February 2014. Since that time a number of key technical challenges have been solved and LT-Pyrkal will now proceed with the assembly of the new 3D printer, which will be used for both prototyping and distributed manufacturing with specific applications in electronics, aerospace, automotive, mechanical and healthcare industries.
“With our partner LT-PYRKAL, we are assembling and testing our first 3D printer which will have the ability to use an extended and varied list of alloys to “print” metal components for targeted industries,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our technical team of scientists have identified a unique approach to handle high-performance metal alloys with our compact high-speed 3D print technologies. The advantage of our design is the compactness, speed and quick transition from prototyping to 3D manufacturing at all levels of production. Add the ability to handle high-performance metal alloys and the size of the market grows considerably. We are excited about the prospect of being a key leader in an industry that will revolutionize manufacturing.”
LT-PYRKAL is a long time contract partner of Zecotek which developed a number of key electro-mechanical elements for Zecotek`s patented 3D display technology. The company is known for its experience in automation systems, component design and product development across many industries. It has working relations with both small and large organizations and has completed large projects for local government agencies.
“We look forward to continuing to build on our growing relationship with Zecotek by completing the assembly and testing of their first compact high-speed 3D printer and assist them to move to full production and sales,” said Mr. Gagik Buniatyan, General Director of LT-PYRKAL.
3D printing is the process of making three dimensional solid objects from a digital model by laying down successive layers of material in different shapes. Zecotek and LT-PYRKAL have identified a unique method of printing with high-performance metal alloys with its proprietary compact, high-speed 3D printing technologies. This will provide companies to evaluate a broader range of product models in less time to improve design throughout the product development process. Rapid prototyping enables faster more efficient production, while rapid manufacturing enables higher productivity, economical customization, improved quality and greater efficiency.
Total annual sales and service of 3D printers has reached $2 billion. Leading industry analysts predict continued significant growth with annual sales of 3D printing reaching $4 billion by 2015, and over $10 billion by 2021. The rapid growth in the 3D printing market is due to the improving performance of additive equipment and the expanding range of materials being used. Although 3D printing has now become cheaper and more customizable than regular manufacturing methods, Zecotek and LT-PYRKAL have identified a number of opportunities to improve 3D printing technology. Patents will be filed as required.
-30-
About LT-PYRKAL
LT-PYRKAL is a Greek-Armenian research, development and production company, specializing in crystal growth, laser accessories and components, lasers and systems. LT-PYRKAL was established in 1999 and today employs over 250 highly qualified specialists and occupies over 30,000 square meters of industrial facilities for synthetic crystal growth, opto-mechanics and laser electronics manufacturing, and laser and EO Systems development. For more information please visit: http://www.lt-pyrkal.com/en/.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Michael Minder
Zecotek Photonics Inc.
Unit 1120 – 21331 Gordon Way
Richmond, BC V6W 1J9
T: (604) 783-8291
ir@zecotek.com
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors – mining, oil & gas, technology & life sciences, diversified industries and clean technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Nice announcement. Even more significant... no signs of dumpage... yet!!
Stoppage of dumpage is the real test!!
Any institutional holdings yet? I don't see any such filings.
Hard to believe with the established reputations of our founders.
Egad... what a list! Impressive, to say the least. Please help me understand how all of these could not be considered significant events that must be disclosed.
Just listened to the TRXC conference call. Now I'm really confused. Just how many up and coming robotic surgery firms are there? Why should I consider TITXF to be better than TRXC? How about SMA, OCLR, NSTG, EXAC, CERS, RTIX, INGN, CRY, TRIV or CLFD?
I'm not a surgeon or a doctor? Just an individual investor.
Agreed. We'll now become a world force in lithium supply. Wonder what happens to the planned battery plant?
30 April 2014
GALAXY SIGNS BINDING AGREEMENT
FOR SALE OF 100% OF JIANGSU
HIGHLIGHTS
?
Binding Share Purchase Agreement si
gned with Sichuan Tianqi Lithium I
ndustries Inc. for the sale of
100% of the Jiangsu Lithium Carbonate plant in China,
?
Transaction based on an enterprise value of US$230
million (approximately A$249 million), comprising
cash consideration of US$122milli
on (approximately A$132 million) and assumption of all Chinese debt,
?
On closing Galaxy to have pro forma positive
net cash of approximately A$62 million,
?
Galaxy to maintain industry focus and concentrate on th
e Sal de Vida lithium brine project in Argentina.
Interesting. Maybe Posco is the unnamed new partner/backer. Hopefully, we'll hear something by Tuesday.
Looks like we wait until Tuesday, March 4 to learn what Galaxy management is negotiating.
Purely a wild-ass speculation, but wouldn't it be a thrill if it somehow related to this:
This afternoon, Tesla Motors released details on its proposed "Gigafactory" to build lithium-ion cells for its future electric cars.
To provide enough cell capacity to build a projected 500,000 electric vehicles in the year 2020, Tesla would require more cells than last year's entire global production.
Hence, as CEO Elon Musk has said several times, it will need its own gigantic U.S.-based cell assembly plant, which he dubbed the "gigafactory."
10,000 shares traded at $0.0004?
That's $4 worth.
What, perchance, do you see happening?
Whoa... the correct ticker is AFRMF. Fidelity bshows 12,825 shares traded. Last price $4.42
Pre-Market trades going through in the $3.20's.
"Cheap scanner??" Please elaborate.
Gary, the recent Jay Leno video seems to have drawn fresh interest in FARO with its edge scan arm. Have you given thought to discussing 3d scanners on this board as a compliment to its 3d printers and 3d software?
After hours close $29.24!!
Lots of recent activity in the Admiralty lawsuit. Maybe, just maybe, it relates to UNDR.
http://iapps.courts.state.ny.us/iscroll/SQLData.jsp?IndexNo=110349-2010
"Real stem cell companies are privately held"
How about the long term leader of the pack... BioTime?
You can polish it while he takes it into consideration.
Send it NOW!!
Send him the information NOW!
Why do you need any votes from us?
As a follower of this board who already holds a comfortable position in Arcam, I too as inspired by ONVO. In fact, I had a position in ONVO that I recently sold off.
My reasoning for selling was that ONVO provides a mechanism for applying biogenics to a surface and thus building tissue and organs. But the science behind the biogenics is not their strength. To me, the biogenics creators are the key... so I bought ISCO and BTX instead of ONVO.
Just a few key statements could change EVERYTHING!!
The market is quite good at foreseeing projected growth of profitable companies. On these boards the great thinkers argue endlessly about how far each of them can project a straight line.
When it comes to high technology innovation there is absolutely no appreciation for what is involved. But the critics sure do express strong opinions!!
How long would they have given Edison to invent the phonograph? Or the telephone? However long it took, they certainly would have been critical and they would have made their feelings well known.
To my eyes, the pace of invention here has been astounding. Management has remained faithful to their country and to their shareholders. They have the best science advisory team in the world and they maintain firm relationships with our prime early customers. For these reasons my trust lies with our management team and not with the critics.
They who cannot see what is happening here should leave and the price drops show that they are. I'm in for the long haul and I know we'll see astounding progress very soon.
Email sent.
Upward momentum increasing. The combination of a micro-sized float along with some recent large (institutional?) buys may have eliminated all trading shares and raised a sign saying "investors only."
Your rationale makes sense if you're talking about managing a company that produces or sells run-of-the-mill manufactured products.
But Natcore is about breakthrough scientific invention leading to industry dominating technology.
The goal is NOT to get the first product out there so an accountant can show revenue and profit on the books before the company goes bankrupt.
Rather, the goal is to INVENT a technology that is reproducible on an industrial scale and is so superior to todays technology that an entire industry will adopt it. Further, the goal is to introduce the technology in such a way that Natcore realizes the full financial benefit of its creativity.
Breakthrough invention cannot be scheduled precisely. And the commercial introduction of an entire new technology must be thought through in a manner that our current management seems well qualified to administer.
Thank God the current management team is running this show and not Kungfu!
WOW!!
Greenlight Capital Re, Ltd. (Nasdaq:GLRE) today announced financial results for the second quarter ended June 30, 2013. Greenlight Re reported net income of $28.5 million for the second quarter of 2013 compared to a net loss of $36.1 million for the same period in 2012. Fully diluted net income per share was $0.76 compared to a net loss per share of $0.98 for the same period in 2012.
Fully diluted adjusted book value per share was $24.20 as of June 30, 2013, an 8.3% increase from $22.34 per share as of June 30, 2012.
"We are pleased to report positive performance from both our underwriting and investing operations during the quarter," said Bart Hedges, Chief Executive Officer of Greenlight Re. "While the reinsurance environment remains quite competitive, we continue to provide superior service and maintain strong relationships with our existing clients."
Financial and operating highlights for Greenlight Re for the second quarter ended June 30, 2013 include:
Gross written premiums in the second quarter of 2013 were $135.2 million, compared to $84.0 million in the second quarter of 2012; net earned premiums were $133.0 million, an increase from $130.0 million reported in the prior-year period.
Underwriting income of $11.7 million was reported for the second quarter of 2013, compared to underwriting income of $4.8 million in the second quarter of 2012.
The combined ratio for the six months ended June 30, 2013 was 98.3% compared to 100.8% for the six months ended June 30, 2012.
A net investment gain of 2.0% on Greenlight Re's investment portfolio managed by DME Advisors, LP was reported for the second quarter 2013. This compares to a net investment loss of 3.3% in the second quarter of 2012. For the first six months of 2013, net investment income was $85.4 million, representing a gain of 7.9%, compared to net investment income of $34.7 million during the comparable period in 2012 when Greenlight Re reported a 3.0% return.
"Our investment portfolio performed adequately during the quarter and side-stepped most of the June turbulence," stated David Einhorn, Chairman of the Board of Directors. "Our underwriting team is actively engaged in providing excellent service to our existing clients and remains focused on identifying new profitable opportunities."
Conference Call Details
Greenlight Re will hold a live conference call to discuss its financial results for the second quarter of 2013 on Tuesday, July 30, 2013 at 9:00 a.m. Eastern time. The conference call title is Greenlight Capital Re, Ltd. Second Quarter 2013 Earnings Call.
To participate, please dial in to the conference call at:
U.S. toll free 1-888-317-6016
International 1-412-317-6016
The conference call can also be accessed via webcast at:
http://services.choruscall.com/links/glre130730.html
A telephone replay of the call will be available from 11:00 a.m. Eastern time on July 30, 2013 until 9:00 a.m. Eastern time on August 7, 2013. The replay of the call may be accessed by dialing 1-877-344-7529 (U.S. toll free) or 1-412-317-0088 (international), access code 10030522. An audio file of the call will also be available on the Company's website, www.greenlightre.ky.
Regulation G
Fully diluted adjusted book value per share is a non-GAAP measure and represents basic adjusted book value per share combined with the impact from dilution of share based compensation including in-the-money stock options and RSUs as of any period end. Book value is adjusted by subtracting the amount of the non-controlling interest in joint venture from total shareholders' equity to calculate adjusted book value. We believe that long term growth in fully diluted adjusted book value per share is the most relevant measure of our financial performance. In addition, fully diluted adjusted book value per share may be of benefit to our investors, shareholders and other interested parties to form a basis of comparison with other companies within the reinsurance industry.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the U.S. federal securities laws. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. Federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements made on behalf of the Company. These risks and uncertainties include the impact of general economic conditions and conditions affecting the insurance and reinsurance industry, the adequacy of our reserves, our ability to assess underwriting risk, trends in rates for property and casualty insurance and reinsurance, competition, investment market fluctuations, trends in insured and paid losses, catastrophes, regulatory and legal uncertainties and other factors described in our annual report on Form 10-K filed with the Securities Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Greenlight Capital Re, Ltd.
Greenlight Re (www.greenlightre.ky) is a NASDAQ listed company with specialist property and casualty reinsurance companies based in the Cayman Islands and Ireland. Greenlight Re provides a variety of custom-tailored reinsurance solutions to the insurance, risk retention group, captive and financial marketplaces. Established in 2004, Greenlight Re selectively offers customized reinsurance solutions in markets where capacity and alternatives are limited. With a focus on deriving superior returns from both sides of the balance sheet, Greenlight Re's assets are managed according to a value-oriented equity-focused strategy that complements the Company's business goal of long-term growth in book value per share.
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30, 2013 and December 31, 2012
(expressed in thousands of U.S. dollars, except per share and share amounts)
June 30, 2013 December 31, 2012
(unaudited) (audited)
Assets
Investments
Debt instruments, trading, at fair value $ 8,506 $ 1,763
Equity securities, trading, at fair value 912,202 1,042,715
Other investments, at fair value 93,741 133,450
Total investments 1,014,449 1,177,928
Cash and cash equivalents 177,838 21,890
Restricted cash and cash equivalents 1,226,080 1,206,837
Financial contracts receivable, at fair value 56,117 22,744
Reinsurance balances receivable 171,849 173,221
Loss and loss adjustment expenses recoverable 20,136 34,451
Deferred acquisition costs, net 63,712 59,177
Unearned premiums ceded 2,901 3,616
Notes receivable 15,919 19,330
Other assets 6,269 3,559
Total assets $ 2,755,270 $ 2,722,753
Liabilities and equity
Liabilities
Securities sold, not yet purchased, at fair value $ 950,076 $ 908,368
Financial contracts payable, at fair value 27,345 19,637
Due to prime brokers 249,728 326,488
Loss and loss adjustment expense reserves 301,859 356,470
Unearned premium reserves 207,726 188,185
Reinsurance balances payable 35,307 35,292
Funds withheld 10,184 17,415
Other liabilities 9,906 10,488
Performance compensation payable to related party 21,923 —
Total liabilities 1,814,054 1,862,343
Equity
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) — —
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 30,617,161 (2012: 30,447,179): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,949 (2012: 6,254,949)) 3,687 3,670
Additional paid-in capital 494,509 492,469
Retained earnings 410,802 325,569
Shareholders' equity attributable to shareholders 908,998 821,708
Non-controlling interest in joint venture 32,218 38,702
Total equity 941,216 860,410
Total liabilities and equity $ 2,755,270 $ 2,722,753
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the three and six months ended June 30, 2013 and 2012
(expressed in thousands of U.S. dollars, except per share and share amounts)
Three months ended June 30 Six months ended June 30
2013 2012 2013 2012
Revenues
Gross premiums written $ 135,198 $ 83,986 $ 262,162 $ 236,206
Gross premiums ceded (2,514) 4,602 1,464 (6,393)
Net premiums written 132,684 88,588 263,626 229,813
Change in net unearned premium reserves 316 41,426 (21,155) 1,789
Net premiums earned 133,000 130,014 242,471 231,602
Net investment income (loss) 24,247 (36,896) 85,386 34,711
Other income (expense), net (488) (236) (100) (448)
Total revenues 156,759 92,882 327,757 265,865
Expenses
Loss and loss adjustment expenses incurred, net 78,345 87,337 144,623 150,644
Acquisition costs, net 42,936 37,905 84,232 73,930
General and administrative expenses 5,943 4,359 9,703 8,982
Total expenses 127,224 129,601 238,558 233,556
Income (loss) before income tax expense 29,535 (36,719) 89,199 32,309
Income tax benefit (expense) (142) 201 (450) (62)
Net income (loss) including non-controlling interest 29,393 (36,518) 88,749 32,247
Income (loss) attributable to non-controlling interest in joint venture (893) 449 (3,516) (3,183)
Net income (loss) $ 28,500 $ (36,069) $ 85,233 $ 29,064
Earnings (loss) per share
Basic $ 0.77 $ (0.98) $ 2.32 $ 0.80
Diluted $ 0.76 $ (0.98) $ 2.27 $ 0.78
Weighted average number of ordinary shares used in the determination of earnings (loss) per share
Basic 36,830,046 36,660,267 36,780,438 36,605,610
Diluted 37,537,500 36,660,267 37,481,162 37,338,484
The following table provides the ratios for the three months ended June 30, 2013 and 2012:
Six months ended June 30 Six months ended June 30
2013 2012
Frequency Severity Total Frequency Severity Total
Loss ratio 65.4% (144.2)% 59.6% 67.5% 7.9% 65.0%
Acquisition cost ratio 35.2% 19.6% 34.7% 32.6% 15.9% 31.9%
Composite ratio 100.6% (124.6)% 94.3% 100.1% 23.8% 96.9%
Internal expense ratio 3.3% 3.0%
Corporate expense ratio 0.7% 0.9%
Combined ratio 98.3% 100.8%
CONTACT: Garrett Edson
ICR
(203) 682-8331
IR@greenlightre.ky
Media:
Brian Ruby
ICR
(203) 682-8268
Brian.ruby@icrinc.com
Quoted from Street Authority's Game Changing Stocks
"In this year's first quarter, the company posted an operating loss of $10.3 million. And $13.8 million of its reported operations expenses was a non-cash charge for depreciation and amortization. Without these charges, which make up for money spent long ago, Gogo would have posted an operating profit, or at least broken even -- and that's been true for some time. Yet the bottom line is still jacked, with nearly $100 million in red ink in 2012.
The important question, then, which is always posed in all of the best business schools, is this: What gives?
If the company is so close to an operating profit, then what is killing its bottom line? What's eating away at the south end of the income statement?
In a word, the shareholders' cut.
More formally, the dividend (which acts a lot like "interest") that preferred shareholders are getting right now. In 2012, taking care of the preferreds accounted for $62.8 million of a $95.6 million net loss. That's two-thirds, or 67%.
Hold onto your hat, though. Careful readers of the prospectus will realize something very important.
This expense disappears immediately.
You see, only 11 million shares were offered -- that is, actually "sold" -- in the IPO. But scads more are being created. You see, all of the preferreds are being converted to common shareholders. The number of shares outstanding after the offering won't be 11 million. It will be 86 million.
Presto! Gogo just wiped away the biggest expense on its income statement!
Absent noncash charges for depreciation and the cost of servicing the preferreds, Gogo looks like a potential profit juggernaut if it can control other expenses, even without adding more customers.
This high degree of inside ownership is usually a good thing over the long term. It's an immutable law of economics that everyone will act in his own best interest, and the preferred shareholders will remain owners of the company. In fact, they're locked in for a while.
With so much tied up in these shares, you can imagine that they want the company to do well. They want to see strong quarters and good performance that will drive their stock price up. They will insist that management control selling, general and administrative expenses and engineering expenses, which are currently fairly outsized. Further, they will insist that the marketing dollars capture a solid return on investment.
All in all, they will demand that the bottom line be printed in black ink. They have hundreds of millions of reasons to make sure."
Fidelity adjusted my shares on 7/22.
I sure hope you're right. But I found that as of 6/14, the group that's sueing UNDR got permission to change attorneys.
http://iapps.courts.state.ny.us/iscroll/SQLData.jsp?IndexNo=110349-2010
So maybe something is happening.
No one tells me to buy anything. That's up to me. But I peeked and I liked what I saw.
Thanks again for the pointer over here.
Karin, thanks for the PM on ISCO. Sounds interesting. Bought an opening position to retain my interest while I investigate further.
Wall Street is all excited about Organovo lately. I wonder how long it will take those geniuses to realize that many other companies can also make 3d printers to squirt out human cells. But its really BioTime that deserves the recognition... because Biotime has the key to making the cells that the machine squirts into 3d layers!!
Bradford, your bad judgements about Chinese companies have cost me dearly. The difference is that this one was picked by the Swedes and is being supported by them.
My bet is that the Swedish selection and support matters BIG TIME.
These people are a lot brighter than these boards tend to appreciate. They have the most advanced solar technology in the world and the smartest solar scientists on their payroll.
As of late we see a new CFO, Updated patents, European listing on the Frankfurt exchange, new... high powered IR, plus big time technology accomplishments with black solar and flexible solar panels.
Grab all the shares you can and prepare for blastoff! Once it starts, this one's not stopping.